ArticleCureus2024
From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case illustrates an example of a patient with mild asthma who experiences a severe life-threatening exacerbation. This patient's experience is one of many that challenges the common misperception that mild, well-controlled asthma is not at risk for severe life-threatening exacerbations. The case exploration highlights the data fueling the new 2019/2020 Global Initiative for Asthma (GINA) guidelines, pharmaco-inequity, and barriers to healthcare access which can increase the risk for poor asthma outcomes. The graphic illustrates when patients with asthma, including those with mild asthma, may benefit from referral to an allergist-immunologist. Overall, this case underscores the importance of bridging the gap between generalists and allergist-immunologists to better serve an oft-overlooked patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.